CD155 Is a Potential Biomarker in Basal Cell Carcinoma

Am J Dermatopathol. 2023 Oct 1;45(10):730-732. doi: 10.1097/DAD.0000000000002502. Epub 2023 Jul 31.

Authors

Jesús Iván Martínez-Ortega¹, Elvis Martinez-Jaramillo², Mary Fafutis-Morris³

Affiliations

¹ Dermatological Institute of Jalisco, "Dr. José Barba Rubio", Department of Dermatology, Zapopan, Jalisco, México.
² Department of Pathology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
³ Immunology Department, University of Guadalajara, Guadalajara, Jalisco, México.

PMID: 37522595
DOI: 10.1097/DAD.0000000000002502

No abstract available

Publication types

Editorial

MeSH terms

Biomarkers
Carcinoma, Basal Cell*
Humans
Skin Neoplasms*

Substances

Biomarkers
poliovirus receptor